In vitro effects of voxelotor on red blood cell senescence and rheological behavior in sickle cell anemia
{{output}}
Voxelotor, a hemoglobin S polymerization inhibitor, has been shown to reduce anemia in sickle cell anemia (SCA) but its effects on vaso-occlusive crisis frequency are limited. Its recent market withdrawal due to concerns over treatment-related excess mortality... ...